Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy

Area of Science:

• Nephrology
• Endocrinology
• Oxidative Stress Research

Background:

• Advanced glycation end products (AGEs) and their receptor (RAGE) contribute to oxidative stress in diabetic nephropathy (DN).
• Understanding the role of the AGE-RAGE axis is crucial for developing effective DN treatments.
• Therapeutic strategies targeting AGE accumulation and RAGE signaling are under investigation.

Purpose of the Study:

• To evaluate the effects of RAGE deletion, AGE accumulation inhibition, and dietary AGE reduction on oxidative parameters in diabetic nephropathy.
• To assess the impact of these interventions on renal function and histopathology in a mouse model of DN.
• To determine the clinical implications of targeting the AGE-RAGE axis in DN.

Main Methods:

• Diabetic and control wild-type mice, along with RAGE-deficient mice, were fed high- or low-AGE diets for 24 weeks.
• Alagebrium chloride, an AGE accumulation inhibitor, was administered to specific groups.
• Evaluated parameters included albuminuria, hyperfiltration, glomerulosclerosis, oxidative stress markers (ROS), renal RAGE expression, and AGE levels.

Main Results:

• Diabetic RAGE-deficient mice showed protection against albuminuria, hyperfiltration, glomerulosclerosis, and reduced oxidative stress.
• Alagebrium treatment improved glomerulosclerosis, tubulointerstitial expansion, and hyperfiltration but not albuminuria.
• Low-AGE diets did not provide renoprotection or reduce the AGE burden or oxidative stress.

Conclusions:

• Blocking the AGE-RAGE axis through RAGE deletion or alagebrium treatment demonstrates renoprotective effects in diabetic nephropathy.
• Dietary modification with low-AGE content was ineffective in mitigating DN.
• Targeting the AGE-RAGE axis offers potential therapeutic avenues for DN, with varying efficacy depending on the approach.